Personalized medicine, says this article in The Scientist, could breathe new life into failed drug candidates. "If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market," Personalized Medicine Coalition's Edward Abrahams says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.